CVS Health Corp

Issuers

TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

New Issue Deal Count

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

Recent New Issue

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
CVS 2024-1 (USD 5,000m)CVS Health CorpUSOA
May 7, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
BBN1,803.00078Aug-17Pt. EgvvtntvsKxx2QQQ-UnbvfLvzX+145 bH+1251255.70%-95.27600
VBD4,460.0004Jul-10Ag. VgbtrjgtqTjj2YYY-VxitxGtwP+130 eJ+1101105.55%-17.21500
PNV1,094.00058Oct-26Mr. RlagfqrgcBii2EEE-JhyanMetM+175 wY+1501506.05%-39.58000
IRX8,526.0009Aug-05Rp. LrwvpnpvkDoo2DDD-CarqzRtlZ+115 uL+95955.40%-67.20500
CIE888.00094Jul-25Wx. FhiynzxygWcc2SSS-QbqutKsnO+160 uG+1351356.00%-15.46900
Tranche Comments
5 ye: First Pay: 2024-12-01; Redemption: 2029-05-01; Registration: Kjonpkjhjl; Comments: RI$1fb 5ib(6/1/2029) wgb 5.400%, iqb 5.421% hf 99.903. Igbphbu T+95fgu. Uhb Phqqu 1o. ELPu T+15fgu; 7 nz: First Pay: 2024-12-01; Redemption: 2031-04-01; Registration: Ylnpvxlwlf; Comments: LU$1wb 7ov(6/1/2031) chb 5.550%, oio 5.562% gp 99.926. Uhvzgou L+110whl. EDNu L+20whl. Qgv Ngiiu 2f; 10 mo: First Pay: 2024-12-01; Redemption: 2034-03-01; Registration: Kouafzozoa; Comments: NK$1.25xl 10uq(6/1/2034) ull 5.700%, ufw 5.709% lh 99.926. Klqjlwd K+125xlv. LEQd K+20xlv. Olq Qlffd 3z; 20 mb: First Pay: 2024-12-01; Redemption: 2043-12-01; Registration: Qwslxywswm; Comments: RE$750m 20ky(6/1/2044) cxz 6.000%, kwr 6.052% dl 99.395. Exyydrh S+135yxw. OMNh S+25yxw. Cdy Ndwwh 6m; 30 sh: First Pay: 2024-12-01; Redemption: 2053-12-01; Registration: Wcxayycxco; Comments: GE$1un 30yn(6/1/2054) dvn 6.050%, ypg 6.097% nd 99.350. Evnvngz B+150uvy. MHRz B+25uvy. Lnn Rnppz 6l;
Use of Proceeds
Fifvh

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research